Can nicotine be used medicinally in Parkinson's disease?
pH as a biomarker of neurodegeneration in Huntington's disease: a translational rodent-human MRS study.
Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation.
[Pathogenesis and treatment of idiopathic nephrotic syndrome in adults].
Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging.
Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease.
Clinicopathological study of glomerular diseases associated with sarcoidosis: a multicenter study.
The spectrum of renal involvement in patients with inflammatory myopathies.
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial.
Clinical routine use of dopamine transporter imaging in 516 consecutive patients.